Dipeptidyl Peptidase-4 Inhibitor Prevents the Progression of Heart Failure After Myocardial Infarction

被引：0
|
作者：
Kubota, Akihiko [1 ]
Takano, Hiroyuki [2 ]
Hasegawa, Hiroshi [1 ]
Kobara, Yuka [1 ]
Wang, Haixiu [2 ]
Nagamine, Akari [2 ]
Ono, Ayaka [2 ]
Kameda, Yoshihito [1 ]
Hirose, Masanori [1 ]
Tadokoro, Hiroyuki [3 ]
Kobayashi, Yoshio [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan
[3] Tokai Univ, Sch High Technol Human Welf, Dept Biomed Engn, Numazu, Japan
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Ischemic heart disease; Pharmacology; Heart failure;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11421
引用
收藏
页数：1
相关论文
共 50 条
  • [21] New Synthetic Route to a Dipeptidyl Peptidase-4 Inhibitor
    Lafrance, Danny
    Caron, Stephane
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (03) : 409 - 414
  • [22] Vildagliptin:: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties
    Ahrén, B
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (04) : 431 - 442
  • [23] Dipeptidyl peptidase-4 independent cardiac dysfunction links saxagliptin to heart failure
    Koyani, Chintan N.
    Kolesnik, Ewald
    Woelkart, Gerald
    Shrestha, Niroj
    Scheruebel, Susanne
    Trummer, Christopher
    Zorn-Pauly, Klaus
    Hammer, Astrid
    Lang, Petra
    Reicher, Helga
    Maechler, Heinrich
    Groschner, Klaus
    Mayer, Bernd
    Rainer, Peter P.
    Sourij, Harald
    Sattler, Wolfgang
    Malle, Ernst
    Pelzmann, Brigitte
    von Lewinski, Dirk
    BIOCHEMICAL PHARMACOLOGY, 2017, 145 : 64 - 80
  • [24] Cardiovascular safety of dipeptidyl peptidase-4 inhibitors: recent evidence on heart failure
    Kankanala, Saumya Reddy
    Syed, Rafay
    Gong, Quan
    Ren, Boxu
    Rao, Xiaoquan
    Zhong, Jixin
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (05): : 2450 - 2458
  • [25] Effects of Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Diabetes
    Yamamoto, Masayoshi
    Seo, Yoshihiro
    Yamada, Yu
    Nakagawa, Taishi
    Nakatsukasa, Tomofumi
    Sugano, Akinori
    Hamada, Yoshie
    Machino, Tomoko
    Ishizu, Tomoko
    Aonuma, Kazutaka
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S198 - S198
  • [26] Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
    Inthachai, Tharnwimol
    Lekawanvijit, Suree
    Kumfu, Sirinart
    Apaijai, Nattayaporn
    Pongkan, Wanpitak
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    EXPERIMENTAL PHYSIOLOGY, 2015, 100 (06) : 667 - 679
  • [27] Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
    Sauve, Meghan
    Ban, Kiwon
    Momen, M. Abdul
    Zhou, Yu-Qing
    Henkelman, R. Mark
    Husain, Mansoor
    Drucker, Daniel J.
    DIABETES, 2010, 59 (04) : 1063 - 1073
  • [28] Dipeptidyl peptidase-4 inhibitor prevents diabetic nephropathy through STRA6 signaling
    Lin, Kun-Der
    Chen, Chao-Hung
    Lin, Hsing-Yi
    Lee, Mei-Yueh
    Lee, Yu-Li
    Hung, Wei-Wen
    Jiang, He-Jiun
    Hsiao, Pi-Jung
    Shin, Shyi-Jang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S61 - S61
  • [29] Dipeptidyl Peptidase-4 Inhibitor Can Ameliorate the Decreased Exercise Capacity in Heart Failure After Myocardial Infraction in Mice With the Skeletal Muscle Switch to Oxidative Fiber Type
    Masaki, Yoshihiro
    Kinugawa, Shintaro
    Fukushima, Arata
    Homma, Tsuneaki
    Suga, Tadashi
    Takada, Shingo
    Kadoguchi, Tomoyasu
    Furihata, Takaaki
    Okita, Koichi
    Tsutsui, Hiroyuki
    CIRCULATION, 2012, 126 (21)
  • [30] Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor
    Boulton, David W.
    CLINICAL PHARMACOKINETICS, 2017, 56 (01) : 11 - 24
12345